Who owns EDSA?
Institutional ownership of Edesa Biotech Inc. from Form 13F, Q2 2026
33 institutional managers reported holding Edesa Biotech Inc. (EDSA) in Form 13F filings for Q2 2026, with 3,754,523 shares worth $30.0M. The largest reported holder was Velan Capital Investment Management LP. Managers that filed both quarters added a net 1,110,802 shares (+42.0%). 11 opened new positions and 6 sold out.
- Funds holding
- 33
- Value held
- $30.0M
- New / sold out
- 11 / 6
- Net shares, same filers
- +42.0%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of EDSA
Share of 13F holdings is each fund's shares as a share of the 3,754,523 EDSA shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Millennium Management LLC New+$4.6M
- Stonepine Capital Management, LLC Added+$3.0M
- Boxer Capital Management, LLC New+$1.7M
- XTX Topco Ltd New+$287K
- HRT Financial LP New+$256K
- Two Sigma Investments, LP New+$114K
- UBS Group AG Added+$36K
- Geode Capital Management, LLC Added+$31K
- Federation des caisses Desjardins du Quebec New+$21K
- Morgan Stanley New+$11K
Biggest sellers in Q2 2026
- Jane Street Group, LLC Trimmed-$352K
- Commonwealth Equity Services, LLC Sold out-$183K
- Scientech Research LLC Sold out-$160K
- Rubric Capital Management LP Trimmed-$146K
- Virtu Financial LLC Sold out-$137K
- Schonfeld Strategic Advisors LLC Sold out-$103K
- Vanguard Capital Management LLC Trimmed-$34K
- Scotia Capital Inc. Trimmed-$12K
- Citigroup Inc Sold out-$3K
- BlackRock, Inc. Trimmed-$2K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $10.0M and sold $1.1M; 6 added and 5 trimmed.
Schedule 13D and 13G filings on EDSA
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-16Boxer Capital Management, LLC SCHEDULE 13G filed by Edesa Biotech Inc.Schedule 13G
- 2026-11-16STEMPOINT CAPITAL LP SCHEDULE 13G filed by Edesa Biotech Inc.Schedule 13G
- 2026-11-12Adage Capital Management, L.P. SCHEDULE 13G filed by Edesa Biotech Inc.Schedule 13G
- 2026-08-26Stonepine Capital Management, LLC SCHEDULE 13G filed by Edesa Biotech Inc.Schedule 13G
- 2026-06-18INTEGRATED CORE STRATEGIES (US) LLC SCHEDULE 13G filed by Edesa Biotech Inc.Schedule 13G
- 2026-03-16PERCEPTIVE ADVISORS LLC SCHEDULE 13G filed by Edesa Biotech Inc.Schedule 13G
- 2025-05-15Nantahala Capital Management, LLC SCHEDULE 13G filed by Edesa Biotech Inc.Schedule 13G
- 2025-02-25Stonepine Capital Management, LLC SCHEDULE 13G filed by Edesa Biotech Inc.Schedule 13G
Questions about EDSA ownership
- Who owns EDSA stock?
- 33 institutional investment managers reported EDSA positions in their Form 13F filings for Q2 2026, holding 3,754,523 shares worth $30.0M in total. Velan Capital Investment Management LP reported the largest position.
- Are funds buying or selling EDSA?
- In Q2 2026, 11 managers opened new EDSA positions, 6 added, 5 trimmed and 6 sold out. Managers that filed in both quarters added a net 1,110,802 shares.
- How current is this EDSA institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to EDSA by CUSIP. Options are left out. EDSA news and filings · EDSA insider trades · Top funds